Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY25.11 CNY
Change Today -0.05 / -0.20%
Volume 7.2M
002653 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

xizang haisco pharmaceutic-a (002653) Snapshot

Open
CNY25.49
Previous Close
CNY25.16
Day High
CNY25.55
Day Low
CNY24.90
52 Week High
04/14/15 - CNY29.50
52 Week Low
12/23/14 - CNY16.88
Market Cap
27.1B
Average Volume 10 Days
7.8M
EPS TTM
CNY0.42
Shares Outstanding
1.1B
EX-Date
--
P/E TM
59.8x
Dividend
CNY0.20
Dividend Yield
1.00%
Current Stock Chart for XIZANG HAISCO PHARMACEUTIC-A (002653)

Related News

No related news articles were found.

xizang haisco pharmaceutic-a (002653) Related Businessweek News

No Related Businessweek News Found

xizang haisco pharmaceutic-a (002653) Details

Xizang Haisco Pharmaceutical Group Co., Ltd., together with its subsidiaries, develops, produces, and sells drugs in China. It offers capsules, tablets, granules, and bulk drugs in the fields of cardiovascular, liver disease, diabetes, anti-infection, digestive system, hematological system, nervous and mental system, parenteral nutrition, first-aid, antibiotics, and tumor adjuvant applications. The company’s products include invert sugar, sodium fusidate, polyene phosphatidylcholine, and fat-soluble vitamins. It also develops nalmefene hydrochloride, dolasetron mesylate, cefodizime sodium, and compound amino acids. The company was founded in 2000 and is based in Chengdu, China.

Founded in 2000

xizang haisco pharmaceutic-a (002653) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

xizang haisco pharmaceutic-a (002653) Key Developments

Xizang Haisco Pharmaceutical Group Co., Ltd. to Report Q1, 2015 Results on Apr 23, 2015

Xizang Haisco Pharmaceutical Group Co., Ltd. announced that they will report Q1, 2015 results on Apr 23, 2015

Xizang Haisco Pharmaceutical Group Co., Ltd. Proposes Amendments its Articles of Association

Xizang Haisco Pharmaceutical Group Co., Ltd. at the annual general meeting to be held, proposed changes to the company's registered address and amendments to the company's articles of association.

Xizang Haisco Pharmaceutical Group Co., Ltd. Presents at ChinaBio Partnering Forum 2015, Apr-16-2015 01:30 PM

Xizang Haisco Pharmaceutical Group Co., Ltd. Presents at ChinaBio Partnering Forum 2015, Apr-16-2015 01:30 PM. Venue: Kerry Hotel, Pudong, Shanghai, China.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002653:CH CNY25.11 CNY -0.05

002653 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002653.
View Industry Companies
 

Industry Analysis

002653

Industry Average

Valuation 002653 Industry Range
Price/Earnings 58.6x
Price/Sales 22.6x
Price/Book 12.6x
Price/Cash Flow 57.8x
TEV/Sales 20.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XIZANG HAISCO PHARMACEUTIC-A, please visit www.haisco.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.